Patient and nursing staff perspectives on automated scalp cooling (ASC) for chemotherapy-induced alopecia in breast cancer.

Autor: Ueberroth BE; Department of Hematology/Oncology, University of Colorado Anschutz School of Medicine, 12801 E 17thAve, MS, Aurora, CO, 8117, USA. benjamin.ueberroth@cuanschutz.edu., Kosiorek HE; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ, USA., Nafissi NN; Department of Hematology/Oncology, University of CA-Irvine, Irvine, CA, USA., Ertz-Archambault N; Department of Hematology/Oncology, Creighton University, Phoenix, AZ, USA., Howland A; Mayo Clinic Comprehensive Cancer Center, Phoenix, AZ, USA., Haddad T; Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA., Northfelt DW; Mayo Clinic Comprehensive Cancer Center, Phoenix, AZ, USA.
Jazyk: angličtina
Zdroj: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Jun 06; Vol. 32 (7), pp. 412. Date of Electronic Publication: 2024 Jun 06.
DOI: 10.1007/s00520-024-08611-2
Abstrakt: Purpose: Automated scalp cooling (ASC) is available to patients undergoing chemotherapy for breast cancer to decrease chemotherapy-induced alopecia. This study sought to elucidate patient and chemotherapy nursing perspectives on the ASC experience.
Methods: This is a survey-based study of chemotherapy nursing staff and patients with breast cancer regarding perceived efficacy, side effects, administration, support, and overall opinions of ASC. Chemotherapy nurses across a large, multi-regional tertiary healthcare system completed a one-time survey regarding their experiences in administering ASC. Breast cancer patients who utilized ASC were surveyed along with a control group who underwent alopecia-inducing chemotherapy without ASC use for comparison.
Results: The majority of nursing responses reported inadequate technical support, an increased burden of administering ASC compared to other clinical duties, and that they would not recommend ASC to a family member or friend. Patients who underwent ASC reported significantly less hair loss and were significantly less likely to shave their heads or wear a wig, but this did not translate into significant differences in body image or psychosocial wellbeing responses. Time investment was the most significant burden related to ASC.
Conclusion: Patients using ASC reported significantly less hair loss compared to those not using ASC during alopecia-inducing breast cancer chemotherapy, but this did not translate to improved body image. The majority of chemotherapy nurses reported they lacked adequate support in administering ASC and would not recommend it. Enhanced nursing support may provide a means for improving the ASC experience for both nursing staff and patients.
(© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: